Xyall

Xyall is developing fully automated high-precision tissue dissection solutions as input for molecular diagnostic testing which have witnessed unprecedented advances in technology, offering the promise that clinicians are able to better target and personalize treatment. Yet, selecting tissue samples for molecular testing remains a labor-intensive manual process with limited precision and a high risk of error. This missing link in the chain of precision medicine is filled in by Xyall’s solutions.